Luteinizinghormone-releasing factor-associated peptide(107666-54-6)
- Name: Luteinizinghormone-releasing factor-associated peptide
- Synonyms:GnRH-associatedpeptide; Gonadotropin-releasing hormone-associated peptide; LH-RH associatedpeptide
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:107666-54-6
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 85969-07-9/Budotitane
- 92-90-0/4,4'-bis(3-oxobutanamido)-1,1'-biphenyl
- 72071-49-9/3-(3-benzofuranylalanine)
- 5770-30-9/1,3-Dimethyl-8-isobutyl-1H-purine-2,6(3H,7H)-dione
- 214280-91-8/Benzoic acid,3-(2,3-dihydroxy-3,7-dimethyl- 6-octenyl)-4-hydroxy-5-(3-methyl-2- butenyl)-
- 82947-63-5/3,3-bis(trifluoromethyl)bicyclo(2.2.1)heptane-2,2-dicarbonitrile
- 69024-54-0/4-[4-(acetylamino)-3-bromophenyl]butanamide
- 111163-39-4/Alcohols, C8-10, reaction products with phosphorus oxide (P2O5)
- 119603-16-6/(1R,2S)-3-{[N-(2,4-dimethyloctanoyl)-N,O-dimethyl-L-tyrosyl]amino}-2-{[1-({4-hydroxy-2-[(2-methyl-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]pyrrolidin-1-yl}carbonyl)-2-methylpropyl](methyl)amino}-1-methyl-3-oxopropyl acetate
- 41931-03-7/1-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-methylpiperazine (2E)-but-2-enedioate
- 5321-32-4/potassium [2S-[2alpha,5alpha,6beta(S*)]]-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
- 7065-99-8/N-(3,4-dichlorophenyl)-5-(pyrrolidin-1-ylsulfonyl)pyridin-2-amine
- 6338-49-4/4-methyl-5-[(E)-phenyldiazenyl]-2-(phenylhydrazono)-2H-imidazole
- 143171-89-5/1,4-Benzenedimethanaminium,N1-[2-[dimethyl[[4-[(trimethylammonio)methyl]phenyl]methyl]ammonio]ethyl]-N1,N1,N4,N4,N4-pentamethyl-
- 68052-37-9/Dicyclohexylammonium phosphate (3:1)
- 75896-37-6/dipotassium 2-(2,3-dihydroxypropoxy)-5-dodecylbenzene-1,3-disulfonate
- 33310-71-3/4,4'-[3-[N-[4-Morpholino-2-(1-naphtyl)-2-(2-morpholinoethyl)butyl]formimidoyl]-3-(1-naphtyl)pentamethylene]dimorpholine
- 40591-31-9/ethyl 2-[(cyclohexylcarbamoyl)carbamoyl]-2-(prop-2-en-1-yl)pent-4-enoate
- 72822-01-6/PERGOLIDE SULFOXIDE (50 MG)
- 107666-54-6/Luteinizinghormone-releasing factor-associated peptide
- 105856-39-1/platinum(2+) chloride - 3-(4-chlorophenyl)propane-1,2-diamine (1:2:1)
- 20228-97-1/2-(diethylamino)ethyl (2-chloro-6-methylphenyl)carbamate hydrochloride (1:1)
- 170969-80-9/Heldrichinic acid
- 74313-63-6/Ethanol, 2,2-oxybis-, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, caprolactam-blocked
- 8075-57-8/2-(naphthalen-1-ylcarbamoyl)benzoic acid - 2-(butan-2-yl)-4,6-dinitrophenol (1:1)
- 165391-82-2/cyclohexyl 2-chloro-5-{[(2-methylfuran-3-yl)carbonothioyl]amino}benzoate
- 15266-46-3/(1aR,13S,13aS)-13-Ethyl-1a,4,5,10,11,12,13,13a-octahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole
- 81907-45-1/S-(2-bromoethyl)-L-cysteinyl-N-L-gamma-glutamylglycine
- 6309-81-5/2-(3,4-dihydroxyphenyl)-N,N,N-trimethyl-2-oxoethanaminium
- 138359-82-7/8H-[2]Benzopyrano[3,4-c]indole,4a,5,6,6a-tetrahydro- 10,11-dimethoxy-5-methyl-